Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw

作者：Ohbayashi Yumiko^*; Miyake Minoru; Sawai Fumi; Minami Yuko; Iwasaki Akinori; Matsui Yoshiro

来源：Oral Surgery Oral Medicine Oral Pathology Oral Radiology, 2013, 115(4): E31-E37.

DOI：10.1016/j.oooo.2012.09.006

The management of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still difficult in many cases that do not respond to conservative treatments. We report a case of BRONJ treated by adjunctive teriparatide therapy for 6 months with monitoring of bone turnover markers (at baseline, at 1, 3, and 6 months of treatment, and after 9 months off therapy) and bone scintigraphy (at baseline, 3 and 6 months, and after 9 months off therapy). The patient was a 78-year-old woman with osteoporosis and BRONJ. She had not responded to previous conventional treatment. Teriparatide was added for resolution of BRONJ. The pain disappeared after 1 month, and remarkable bone regeneration was obtained after 6 months, with significantly increasing bone formation and resorption markers. Bone scintigraphy showed regression of the uptake area. This case suggests the usefulness of monitoring bone turnover markers and using bone scintigraphy to increase the effectiveness of teriparatide therapy. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:e31-e37)

• 出版日期2013-4